IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 42 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,178 | -78.2% | 122,354 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 122,354 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -58.3% | 122,354 | 0.0% | 0.00% | – |
| Q1 2022 | $24,000 | -63.6% | 122,354 | 0.0% | 0.00% | – |
| Q4 2021 | $66,000 | -9.6% | 122,354 | 0.0% | 0.00% | – |
| Q3 2021 | $73,000 | +14.1% | 122,354 | +46.1% | 0.00% | – |
| Q2 2021 | $64,000 | – | 83,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 9,800 | $108,054 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |